Mean serum CTGF concentration at baseline was 533.27±451.03 ng/L in the PF-ILD group, 803.32±648.61 ng/L in the post-COVID-19 fibrosis group, and 96.43±28.98 ng/L in the control group. Here, CCN2 is linked to fibrosis.